Xiao-feng N. Zhu
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 141 publications
Morinda officinalis in the prevention and treatment of osteoporosis: A comprehensive review.
Journal: Journal of ethnopharmacology
Published: March 20, 2026
Medicine-food homologous bioactives in metabolic dysregulation-associated osteoporosis: a review of preclinical evidence and potential liver-bone and gut-bone actions.
Journal: Chinese medicine
Published: February 05, 2026
Cell death pathways and targeting therapeutics in cancer therapy.
Journal: Acta pharmacologica Sinica
Published: January 15, 2026
Delivery of miR-29a/29c-3p by serum exosomes promotes osteogenesis through TET3-dependent Sox9 demethylation and PI3K/Akt activation.
Journal: Journal of nanobiotechnology
Published: July 23, 2025
AAK1 activation-mediated iron trafficking drives ferroptotic cell death.
Journal: Nature communications
Published: April 21, 2025
Plastrum Testudinis Stimulates Bone Formation through Wnt/β-catenin Signaling Pathway Regulated by miR-214.
Journal: Chinese journal of integrative medicine
Published: February 05, 2025
Correction: LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
Journal: Molecular cancer
Published: January 26, 2025
EM-12, a natural sesquiterpene lactone extracted from Elephantopus mollis, promotes cancer cell apoptosis by activating ER stress.
Journal: Medical oncology (Northwood, London, England)
Published: November 17, 2024
Synthesis of fluorinated tubastatin A derivatives with bi-, tri-, and tetracyclic cap groups: molecular docking with HDAC6 and evaluation of in vitro antitumor activity.
Journal: RSC medicinal chemistry
Published: November 15, 2024
Lycium barbarum polysaccharide protects BMSCs against cadmium-induced suppression of osteogenic differentiation by modulating autophagy.
Journal: Ecotoxicology and environmental safety
Published: November 12, 2024
Profiling triple-negative breast cancer-specific super-enhancers identifies high-risk mesenchymal development subtype and BETi-Targetable vulnerabilities.
Journal: Molecular cancer
Published: November 10, 2024
Exosomal communication: a pivotal regulator of bone homeostasis and a potential therapeutic target.
Journal: Frontiers in pharmacology
Published: October 23, 2024
Last Updated: 09/26/2026